title: Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue.
abstract: Triple therapy using proton-pump inhibitors (PPIs) in combination with oral antibiotics for the treatment of Helicobacter pylori-associated gastritis has shown increased efficacy for reasons that are still poorly understood. Possible explanations include a direct antibacterial effect of the PPIs or a PPI-mediated increase in bacterial susceptibility to antibiotics. Using an in-vitro model of rat gastric mucosa, we examined fluxes of a radiolabelled marker molecule through the interepithelial tight junctions under normal conditions and under the influence of an acid secretagogue (50 microM histamine) and a PPI (100 microM omeprazole). Paracellular fluxes of the radiolabel (represented by calculation of apparent permeability coefficients) were linear over 2 h. Fluxes of the marker increased significantly after treatment with histamine followed by omeprazole, but were unaltered in paired preparations exposed to the same drugs given in reverse order. Enhancements in paracellular permeability were mirrored in separate experiments using a detergent (Triton X-100), a bile salt (deoxycholate) and an agent that disrupts the cytoskeleton (cytochalasin D) to interfere with tight junctional integrity. The results suggest that exposure of acid-secreting gastric mucosa to omeprazole widens the interepithelial spacing in a manner that may facilitate enhanced macromolecular transport. Increases in antibiotic delivery from the blood to the gastric lumen via such a mechanism may account for the greater eradication rates observed with PPI-based triple therapy in H. pylori-associated gastritis.
authors.affiliation: Department of Pharmacology, University College Dublin, Belfield, Ireland.
authors.forename: Ann M
authors.initials: AM
authors.lastname: Hopkins
authors.forename: Ciara
authors.initials: C
authors.lastname: McDonnell
authors.forename: Niall P
authors.initials: NP
authors.lastname: Breslin
authors.forename: Colm A
authors.initials: CA
authors.lastname: O'Morain
authors.forename: Alan W
authors.initials: AW
authors.lastname: Baird
mesh_terms: D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D018938:Caco-2 Cells; D002463:Cell Membrane Permeability / Q000187:drug effects; D004347:Drug Interactions; D005753:Gastric Mucosa / Q000187:drug effects*; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D009853:Omeprazole / Q000494:pharmacology*; D018408:Patch-Clamp Techniques; D054328:Proton Pump Inhibitors; D051381:Rats
chemical_list: D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors; D006632:Histamine; D009853:Omeprazole